Cabaletta Bio, Inc.
Extract: Bylaws Amendment (Plain English Desc) from a 10-Q on 05/12/2022   Download
SEC Document
SEC Filing

On May 10, 2022, our Board amended our amended and restated bylaws in order to amend Section 8 of Article VI to designate the federal district courts of the United States of America as the exclusive jurisdiction for any litigation arising under the Securities Act, or the By-law Amendment. The Board approved the By-law Amendment, among other reasons, in order to seek to reduce any potential expenses that the Company may incur in connection with any such actions or proceedings by seeking to avoid the Company being required to defend any such potential actions or proceedings in multiple jurisdictions and/or in parallel proceedings in federal and state courts simultaneously.